Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 2, 1996, Pages 617-626

  Meltzer, Eli O ^a   Weiler, John M ^b   Widlitz, Michael D ^c  

^a ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c PFIZER INC   (United States)

Author keywords

Allergic rhinitis; cetirizine; loratadine; park study; placebo; seasonal allergic rhinitis

Indexed keywords

CETIRIZINE; LORATADINE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SYMPTOMATOLOGY;

EID: 0030066686     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70307-X     Document Type: Article

References (31)

1. Naclerio RM. Allergic rhinitis. N Engl J Med 1991;325:860-9.
2. 1-receptor antagonists. Ann Allergy 1991;66:5-17.
3. 1 antihistamines. J ALLERGY CLIN IMMUNOL 1990;86:1040-60.
4. Lockey RF, Findley S, Mitchell DQ, Woehler T, Lieberman P, Nicodemus CF. Effects of cetirizine versus terfenadine in seasonal allergic rhinitis. Ann Allergy 1993;70:311-5.
5. Mansmann HC, Altman RA, Herman BA, et al. Efficacy and safety of cetirizine therapy in perennial allergic rhinitis. Ann Allergy 1992;68:348-53.
6. Kalivas J, Breneman D, Tharp M, et al. Urticaria: clinical efficacy of cetirizine in comparison with hydroxyzine and placebo. J ALLERGY CLIN IMMUNOL 1990;86:1014-8.
7. Spencer CM, Faulds D, Peters DH. Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993;46:1055-80.
8. Backhouse CI, Renton R, Fidler C, Rosenberg RM. Multicentre, double-blind comparison of terfenadine and cetirizine in patients with seasonal allergic rhinitis. Br J Clin Pharmacol 1990;44:88-91.
9. Caiaffa MF, Iudice A, Macchia L, et al. Multicenter double-blind comparative study of terfenadine and cetirizine in hay fever. J Invest Allergol Clin Immunol 1992;2:162-6.
10. Harcup JW, Hawkes G, Saul PA. The efficacy and sedative profile of astemizole and cetirizine in the treatment of grass pollen hayfever in general practice. Br J Clin Pharmacol 1993;47:131-5.
11. Rijntjes E, Ghys L, Rihoux J-P. Astemizole and cetirizine in the treatment of seasonal allergic rhinitis: a comparative double-blind, multicentre study. J Intern Med Res 1990;18:219-24.
12. Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw-Hill Book Company, 1971.
13. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1969;22:719-48.
14. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley & Sons, 1973.
15. Connell JT. A novel method to assess antihistamine and decongestant efficacy. Ann Allergy 1979;42:278-85.
16. Wasserman SI, Broide DH, Marquardt DL. Cetirizine therapy for seasonal allergic rhinitis: alternative dosage schedules. Clin Ther 1991;13:707-11.
17. Falliers CJ, Brandon ML, Buchman E, et al. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy 1991;66:257-62.
18. Panayotopoulos SM, Panayotopoulou ES. Efficacy of cetirizine in the treatment of seasonal allergic rhinoconjunctivitis. Ann Allergy 1990;65:146-8.
19. Simons FER, McMillan JL, Simons KJ. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J ALLERGY CLIN IMMUNOL 1990;86:540-7.
20. Humphreys F, Hunter JAA. The effects of astemizole, cetirizine and loratadine on the time course of weal and flare reactions to histamine, codeine and antigen. Br J Dermatol 1991;125:364-7.
21. 1 inhibiting effects of cetirizine 2HCl and loratadine. Ann Allergy 1990;65:139-42.
22. Del Carpio J, Kabbash L, Turenne Y, et al. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. J ALLERGY CLIN IMMUNOL 1989;84:741-6.
23. Gutkowski A, Bedard P, Del Carpio J, et al. Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis. J ALLERGY CLIN IMMUNOL 1988;81:902-7.
24. Horak F, Bruttmann G, Pedrali P, et al. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis. Arzneim-Forsch/Drug Res 1988;38:12-8.
25. Olsen OT, Nüchel Petersen L, Hoi L, Lorentzen KA, Hindberg Rasmussen W, Svendsen UG. Comparison of loratadine and terfenadine in allergic seasonal rhinoconjunctivitis with emphasis on nasal stuffiness and peak flow. Arzneim-Forsch/Drug Res 1992;42:1227-31.
26. Oei HD. Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with specific regard to onset of action. Ann Allergy 1988;61:436-9.
27. Chervinsky P, Georgitis J, Banov C, Boggs P, Vande Stouwe R, Greenstein S. Once daily loratadine versus astemizole once daily. Ann Allergy 1994;73:109-13.
28. Irander K, Ödkvist LM, Ohlander B. Treatment of hay fever with loratadine - a new non-sedating antihistamine. Allergy 1990;45:86-91.
29. Dockhorn RJ, Bergner A, Connell JT, et al. Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis. Ann Allergy 1987;58:407-11.
30. Bédard P-M, Del Carpio J, Drouin MA, et al. Onset of action of loratadine and placebo and other efficacy variable in patients with seasonal allergic rhinitis. Clin Ther 1992;14:268-75.
31. Dolovich J, Moote DW, Mazza JA, Clermont A, PetitClerc C, Danzig M. Efficacy of loratadine versus placebo in the prophylactic treatment of seasonal allergic rhinitis. Ann Allergy 1994;73:235-9.